{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:14:54Z","timestamp":1792872894944,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["108008\/Z\/15\/Z"],"award-info":[{"award-number":["108008\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The majority of patients with systemic lupus erythematosus (SLE) have high expression of type I IFN-stimulated genes. Mitochondrial abnormalities have also been reported, but the contribution of type I IFN exposure to these changes is unknown. Here, we show downregulation of mitochondria-derived genes and mitochondria-associated metabolic pathways in IFN-High patients from transcriptomic analysis of CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells. CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells from these patients have enlarged mitochondria and lower spare respiratory capacity associated with increased cell death upon rechallenge with TCR stimulation. These mitochondrial abnormalities can be phenocopied by exposing CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells from healthy volunteers to type I IFN and TCR stimulation. Mechanistically these \u2018SLE-like\u2019 conditions increase CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell NAD+\u2009consumption resulting in impaired mitochondrial respiration and reduced cell viability, both of which can be rectified by NAD+\u2009supplementation. Our data suggest that type I IFN exposure contributes to SLE pathogenesis by promoting CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell death via metabolic rewiring.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-22312-y","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T06:03:34Z","timestamp":1617170614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus"],"prefix":"10.1038","volume":"12","author":[{"given":"Norzawani","family":"Buang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunnathaya","family":"Tapeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Whilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Lightstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Behmoaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6347-0005","authenticated-orcid":false,"given":"Guang Sheng","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-3791","authenticated-orcid":false,"given":"Marina","family":"Botto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"22312_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/BOR.0000000000000087","volume":"26","author":"MK Crow","year":"2014","unstructured":"Crow, M. K. Advances in understanding the role of type I interferons in systemic lupus erythematosus. Curr. Opin. Rheumatol. 26, 467\u2013474 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"22312_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24198-1","volume":"8","author":"YM El-Sherbiny","year":"2018","unstructured":"El-Sherbiny, Y. M. et al. A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Sci. Rep. 8, 5793 (2018).","journal-title":"Sci. Rep."},{"key":"22312_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551\u2013565 (2016).","journal-title":"Cell"},{"key":"22312_CR4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/ard.2008.093146","volume":"68","author":"C Landolt-Marticorena","year":"2009","unstructured":"Landolt-Marticorena, C. et al. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann. Rheum. Dis. 68, 1440\u20131446 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"22312_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/jir.2010.0126","volume":"31","author":"P Hertzog","year":"2011","unstructured":"Hertzog, P., Forster, S. & Samarajiwa, S. Systems biology of interferon responses. J. Interferon Cytokine Res. 31, 5\u201311 (2011).","journal-title":"J. Interferon Cytokine Res."},{"key":"22312_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","volume":"25","author":"L Ronnblom","year":"2013","unstructured":"Ronnblom, L. & Eloranta, M. L. The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol. 25, 248\u2013253 (2013).","journal-title":"Curr. Opin. Rheumatol."},{"key":"22312_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.smim.2011.01.009","volume":"23","author":"L Ronnblom","year":"2011","unstructured":"Ronnblom, L., Alm, G. V. & Eloranta, M. L. The type I interferon system in the development of lupus. Semin. Immunol. 23, 113\u2013121 (2011).","journal-title":"Semin. Immunol."},{"key":"22312_CR8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.coi.2012.07.008","volume":"24","author":"PG Bronson","year":"2012","unstructured":"Bronson, P. G., Chaivorapol, C., Ortmann, W., Behrens, T. W. & Graham, R. R. The genetics of type I interferon in systemic lupus erythematosus. Curr. Opin. Immunol. 24, 530\u2013537 (2012).","journal-title":"Curr. Opin. Immunol."},{"key":"22312_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","volume":"213","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A. & Pearce, E. J. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213, 15\u201323 (2016).","journal-title":"J. Exp. Med."},{"key":"22312_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fimmu.2016.00630","volume":"7","author":"SD Fritsch","year":"2016","unstructured":"Fritsch, S. D. & Weichhart, T. Effects of interferons and viruses on metabolism. Front. Immunol. 7, 630 (2016).","journal-title":"Front. Immunol."},{"key":"22312_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.bbrc.2012.05.154","volume":"423","author":"HY Yim","year":"2012","unstructured":"Yim, H. Y. et al. The mitochondrial pathway and reactive oxygen species are critical contributors to interferon-alpha\/beta-mediated apoptosis in Ubp43-deficient hematopoietic cells. Biochem. Biophys. Res. Commun. 423, 436\u2013440 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"22312_CR12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.celrep.2018.09.001","volume":"25","author":"K Gkirtzimanaki","year":"2018","unstructured":"Gkirtzimanaki, K. et al. IFNalpha impairs autophagic degradation of mtDNA promoting autoreactivity of SLE monocytes in a STING-dependent fashion. Cell Rep. 25, 921\u2013933 (2018).","journal-title":"Cell Rep."},{"key":"22312_CR13","doi-asserted-by":"publisher","first-page":"13184","DOI":"10.1074\/jbc.271.22.13184","volume":"271","author":"JA Lewis","year":"1996","unstructured":"Lewis, J. A., Huq, A. & Najarro, P. Inhibition of mitochondrial function by interferon. J. Biol. Chem. 271, 13184\u201313190 (1996).","journal-title":"J. Biol. Chem."},{"key":"22312_CR14","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","volume":"44","author":"D Wu","year":"2016","unstructured":"Wu, D. et al. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity 44, 1325\u20131336 (2016).","journal-title":"Immunity"},{"key":"22312_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clim.2008.07.011","volume":"129","author":"T Vyshkina","year":"2008","unstructured":"Vyshkina, T. et al. Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus. Clin. Immunol. 129, 31\u201335 (2008).","journal-title":"Clin. Immunol."},{"key":"22312_CR16","doi-asserted-by":"publisher","first-page":"8853","DOI":"10.3390\/ijms13078853","volume":"13","author":"HT Lee","year":"2012","unstructured":"Lee, H. T. et al. Leukocyte mitochondrial DNA alteration in systemic lupus erythematosus and its relevance to the susceptibility to lupus nephritis. Int. J. Mol. Sci. 13, 8853\u20138868 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"22312_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","volume":"46","author":"P Gergely Jr.","year":"2002","unstructured":"Gergely, P. Jr. et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 46, 175\u2013190 (2002).","journal-title":"Arthritis Rheum."},{"key":"22312_CR18","first-page":"173","volume":"9","author":"D Fernandez","year":"2010","unstructured":"Fernandez, D. & Perl, A. mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? Discov. Med. 9, 173\u2013178 (2010).","journal-title":"Discov. Med."},{"key":"22312_CR19","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/ndt\/gfn216","volume":"23","author":"SL Lui","year":"2008","unstructured":"Lui, S. L. et al. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB\/W F1 mice. Nephrol. Dial. Transplant. 23, 2768\u20132776 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"22312_CR20","doi-asserted-by":"publisher","first-page":"274ra218","DOI":"10.1126\/scitranslmed.aaa0835","volume":"7","author":"Y Yin","year":"2015","unstructured":"Yin, Y. et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 7, 274ra218 (2015).","journal-title":"Sci. Transl. Med."},{"key":"22312_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","volume":"9","author":"A Perl","year":"2013","unstructured":"Perl, A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat. Rev. Rheumatol. 9, 674\u2013686 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"22312_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1126\/science.aao4555","volume":"360","author":"GS Ling","year":"2018","unstructured":"Ling, G. S. et al. C1q restrains autoimmunity and viral infection by regulating CD8(+) T cell metabolism. Science 360, 558\u2013563 (2018).","journal-title":"Science"},{"key":"22312_CR23","first-page":"477","volume":"56","author":"N Jourde-Chiche","year":"2017","unstructured":"Jourde-Chiche, N. et al. Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis. Rheumatology 56, 477\u2013487 (2017).","journal-title":"Rheumatology"},{"key":"22312_CR24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1136\/ard.2009.108043","volume":"69","author":"PA Lyons","year":"2010","unstructured":"Lyons, P. A. et al. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann. Rheum. Dis. 69, 1208\u20131213 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"22312_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"22312_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"key":"22312_CR27","doi-asserted-by":"publisher","first-page":"e000080","DOI":"10.1136\/lupus-2014-000080","volume":"2","author":"WP Kennedy","year":"2015","unstructured":"Kennedy, W. P. et al. Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE. Lupus Sci. Med. 2, e000080 (2015).","journal-title":"Lupus Sci. Med."},{"key":"22312_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","volume":"5","author":"N Xie","year":"2020","unstructured":"Xie, N. et al. NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct. Target Ther. 5, 227 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"22312_CR29","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu, Y. R. et al. Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion. Nat. Immunol. 21, 1540\u20131551 (2020).","journal-title":"Nat. Immunol."},{"key":"22312_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2217\/ijr.13.59","volume":"8","author":"C Arriens","year":"2013","unstructured":"Arriens, C. & Mohan, C. Systemic lupus erythematosus diagnostics in the \u2018omics\u2019 era. Int. J. Clin. Rheumtol. 8, 671\u2013687 (2013).","journal-title":"Int. J. Clin. Rheumtol."},{"key":"22312_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.122312","volume":"5","author":"WA Haynes","year":"2020","unstructured":"Haynes, W. A. et al. Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus. JCI Insight 5, 1\u201320 (2020).","journal-title":"JCI Insight"},{"key":"22312_CR32","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.38628","volume":"66","author":"L Chiche","year":"2014","unstructured":"Chiche, L. et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol. 66, 1583\u20131595 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"22312_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0961203309103152","volume":"18","author":"V Dhir","year":"2009","unstructured":"Dhir, V., Singh, A. P., Aggarwal, A., Naik, S. & Misra, R. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study. Lupus 18, 785\u2013791 (2009).","journal-title":"Lupus"},{"key":"22312_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney, E. F., Lee, J. C., Jayne, D. R., Lyons, P. A. & Smith, K. G. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612\u2013616 (2015).","journal-title":"Nature"},{"key":"22312_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/art.20745","volume":"52","author":"P Blanco","year":"2005","unstructured":"Blanco, P. et al. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 52, 201\u2013211 (2005).","journal-title":"Arthritis Rheum."},{"key":"22312_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/art.39410","volume":"68","author":"K Kis-Toth","year":"2016","unstructured":"Kis-Toth, K. et al. Selective loss of signaling lymphocytic activation molecule family member 4-positive CD8+ T cells contributes to the decreased cytotoxic cell activity in systemic lupus erythematosus. Arthritis Rheumatol. 68, 164\u2013173 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"22312_CR37","doi-asserted-by":"publisher","first-page":"e1002328","DOI":"10.1371\/journal.ppat.1002328","volume":"7","author":"M Larsen","year":"2011","unstructured":"Larsen, M. et al. Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog. 7, e1002328 (2011).","journal-title":"PLoS Pathog."},{"key":"22312_CR38","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1002\/art.22654","volume":"56","author":"L Couzi","year":"2007","unstructured":"Couzi, L. et al. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum. 56, 2362\u20132370 (2007).","journal-title":"Arthritis Rheum."},{"key":"22312_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature19317","volume":"537","author":"R He","year":"2016","unstructured":"He, R. et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature 537, 412\u2013428 (2016).","journal-title":"Nature"},{"key":"22312_CR40","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"AJ Lee","year":"2018","unstructured":"Lee, A. J. & Ashkar, A. A. The dual nature of type I and type II interferons. Front. Immunol. 9, 2061 (2018).","journal-title":"Front. Immunol."},{"key":"22312_CR41","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.1128\/JVI.02516-10","volume":"85","author":"HD Marshall","year":"2011","unstructured":"Marshall, H. D., Urban, S. L. & Welsh, R. M. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J. Virol. 85, 5929\u20135939 (2011).","journal-title":"J. Virol."},{"key":"22312_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207\u2013211 (2013).","journal-title":"Science"},{"key":"22312_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-immunol-042617-053019","volume":"36","author":"RIK Geltink","year":"2018","unstructured":"Geltink, R. I. K., Kyle, R. L. & Pearce, E. L. Unraveling the complex interplay between T cell metabolism and function. Annu. Rev. Immunol. 36, 461\u2013488 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"22312_CR44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","volume":"13","author":"L Morel","year":"2017","unstructured":"Morel, L. Immunometabolism in systemic lupus erythematosus. Nat. Rev. Rheumatol. 13, 280\u2013290 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"22312_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.canlet.2016.02.047","volume":"375","author":"YA Hsu","year":"2016","unstructured":"Hsu, Y. A. et al. The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6. Cancer Lett. 375, 303\u2013312 (2016).","journal-title":"Cancer Lett."},{"key":"22312_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.20151876","volume":"213","author":"S Caielli","year":"2016","unstructured":"Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213, 697\u2013713 (2016).","journal-title":"J. Exp. Med."},{"key":"22312_CR47","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1136\/annrheumdis-2013-203794","volume":"73","author":"TN Caza","year":"2014","unstructured":"Caza, T. N. et al. HRES-1\/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. Ann. Rheum. Dis. 73, 1888\u20131897 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"22312_CR48","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin, E. NAD(+) in aging, metabolism, and neurodegeneration. Science 350, 1208\u20131213 (2015).","journal-title":"Science"},{"key":"22312_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.celrep.2019.12.014","volume":"30","author":"E Katsuyama","year":"2020","unstructured":"Katsuyama, E. et al. The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep. 30, 112\u2013123 (2020).","journal-title":"Cell Rep."},{"key":"22312_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cmet.2017.10.006","volume":"27","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee, S. et al. CD38-NAD(+)axis regulates immunotherapeutic anti-tumor T cell response. Cell Metab. 27, 85\u2013100 (2018).","journal-title":"Cell Metab."},{"key":"22312_CR51","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1007\/s00018-019-03120-6","volume":"76","author":"Y Ke","year":"2019","unstructured":"Ke, Y. et al. Novel insights into PARPs in gene expression: regulation of RNA metabolism. Cell Mol. Life Sci. 76, 3283\u20133299 (2019).","journal-title":"Cell Mol. Life Sci."},{"key":"22312_CR52","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/anr.1780320815","volume":"32","author":"JT Sibley","year":"1989","unstructured":"Sibley, J. T., Haug, B. L. & Lee, J. S. Altered metabolism of poly(ADP-ribose) in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Arthritis Rheum. 32, 1045\u20131049 (1989).","journal-title":"Arthritis Rheum."},{"key":"22312_CR53","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1091\/mbc.E18-10-0650","volume":"30","author":"MM Murata","year":"2019","unstructured":"Murata, M. M. et al. NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Mol. Biol. Cell 30, 2584\u20132597 (2019).","journal-title":"Mol. Biol. Cell"},{"key":"22312_CR54","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl Acad. Sci. USA 100, 2610\u20132615 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22312_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand, E. F. et al. Trial of anifrolumab in active systemic lupus erythematosus. N. Engl. J. Med. 382, 211\u2013221 (2020).","journal-title":"N. Engl. J. Med."},{"key":"22312_CR56","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan, E. M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271\u20131277 (1982).","journal-title":"Arthritis Rheum."},{"key":"22312_CR57","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri, M. et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 64, 2677\u20132686 (2012).","journal-title":"Arthritis Rheum."},{"key":"22312_CR58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"22312_CR59","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res 41, e108 (2013).","journal-title":"Nucleic Acids Res"},{"key":"22312_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"22312_CR61","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/ni.2687","volume":"14","author":"PM Gubser","year":"2013","unstructured":"Gubser, P. M. et al. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 14, 1064\u20131072 (2013).","journal-title":"Nat. Immunol."},{"key":"22312_CR62","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-1-61779-504-6_22","volume":"837","author":"V Venegas","year":"2012","unstructured":"Venegas, V. & Halberg, M. C. Measurement of mitochondrial DNA copy number. Methods Mol. Biol. 837, 327\u2013335 (2012).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22312-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22312-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22312-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T06:38:20Z","timestamp":1669963100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22312-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22312"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22312-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"18 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1980"}}